Institute of Microsurgery on Extremities, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, People's Republic of China.
Institute of Urology First Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
Stem Cell Res Ther. 2017 Sep 19;8(1):196. doi: 10.1186/s13287-017-0645-8.
Human induced pluripotent stem cells (iPSCs) have been verified as a powerful cell model for the study of pathogenesis in hereditary disease. Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations of PKD or non-PKD genes. The pathogenesis of ADPKD remains unexplored because of the lack of a true human cell model.
Six ADPKD patients and four healthy individuals were recruited as donors of somatic cells from a Chinese ADPKD family without mutations of the PKD genes but carrying SAMSN1 gene deletion. The ADPKD-iPSCs were generated from somatic cells and were induced into kidney-like cells (KLCs) by a novel three-step method involving cytokines and renal epithelium growth medium. Furthermore, we analyzed functional properties of these KLCs by water transportation and albumin absorption assays.
We successfully generated iPSCs from ADPKD patients and differentiated them into KLCs that showed morphological and functional characteristics of human kidney cells. Further, we also found that ADPKD-iPSC-KLCs had a significantly higher rate of apoptosis and a significantly lower capacity for water transportation and albumin absorption compared to healthy sibling-derived differentiated KLCs. Furthermore, knockdown of SAMSN1 in control iPSCs may attenuate differentiation and/or function of KLCs.
These data show that we have created the first iPSCs established from ADPKD patients without mutations in the PKD genes, and suggest that the deletion mutation of SAMSN1 might be involved in the differentiation and/or function of KLCs. ADPKD-iPSC-KLCs can be used as a versatile model system for the study of kidney disease.
人类诱导多能干细胞(iPSC)已被证实是研究遗传性疾病发病机制的强大细胞模型。常染色体显性多囊肾病(ADPKD)是由 PKD 或非 PKD 基因突变引起的。由于缺乏真正的人类细胞模型,ADPKD 的发病机制仍未得到探索。
从一个中国 ADPKD 家族中招募了 6 名 ADPKD 患者和 4 名健康个体作为体细胞供体,该家族无 PKD 基因突变,但携带 SAMSN1 基因缺失。通过涉及细胞因子和肾上皮生长培养基的三步新方法,将体细胞诱导为类肾细胞(KLC),从而生成 ADPKD-iPSC。此外,我们通过水转运和白蛋白吸收测定分析这些 KLC 的功能特性。
我们成功地从 ADPKD 患者中生成了 iPSC,并将其分化为具有人类肾脏细胞形态和功能特征的 KLC。此外,我们还发现,与健康同胞来源的分化 KLC 相比,ADPKD-iPSC-KLC 的凋亡率显著升高,水转运和白蛋白吸收能力显著降低。此外,在对照 iPSC 中敲低 SAMSN1 可能会减弱 KLC 的分化和/或功能。
这些数据表明,我们已经创建了第一个源自 ADPKD 患者且无 PKD 基因突变的 iPSC,并表明 SAMSN1 的缺失突变可能参与了 KLC 的分化和/或功能。ADPKD-iPSC-KLC 可作为研究肾脏疾病的通用模型系统。